Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,038 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

NCT00045864

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • ACRC/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Hoag Cancer Center Newport Beach, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 33 locations
View Trial Details
Completed

Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments

NCT00045877

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • California Oncology of the Central Valley Fresno, California, United States
  • Virginia K. Crosson Cancer Center Fullerton, California, United States
View all 65 locations
View Trial Details
Completed

Xcellerated T CellsTM in Patients With Multiple Myeloma

NCT00078065

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Oncotherapeutics Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Johns Hopkins Medical Institute Baltimore, Maryland, United States
View Trial Details
Completed

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

NCT00168740

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Natioal Medical Center Duarte, California, United States
  • Scripps Memorial Hospital La Jolla, California, United States
  • UCSD Stem Cell Laboratory La Jolla, California, United States
View all 31 locations
View Trial Details

Related conditions